Clinical Trial Update: Nivolumab and Ipilimumab and Radiation Therapy in MSS and MSI High Colorectal and Pancreatic Cancer [Phase 2]

View source ↗

Summary

Phase 2 trial evaluating nivolumab and ipilimumab with radiation therapy in microsatellite-stable and MSI-high colorectal cancer and pancreatic cancer.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Colorectal Cancer
• Pancreatic Cancer

Drugs mentioned

• ipilimumab (ipilimumab)
• nivolumab (nivolumab)

Snippet

Sponsor: Massachusetts General Hospital | Conditions: Microsatellite Stable Colorectal Cancer, Pancreatic Cancer | Phase 2 | Status: ACTIVE_NOT_RECRUITING